The short-lasting spikes of Ca 2+ -dependent Cl -and monovalent cation current evoked by IP 3 or cADPR in pancreatic acinar cells are due to short-lasting elevations of the cytoplasmic Ca 2+ concentration specifically in the apical granular area of the pancreatic acinar cells [6, 13] . It has previously been shown that cADPR evoked Ca 2+ spiking when present in the pipette solution in concentrations of 1 or 10 µM [6] . We stimulated 49 cells with either 1 or 10 µM cADPR, and 44 of these responded with repetitive spikes of Ca 2+ -dependent current ( Figure 1) ; five cells did not respond. Thus, about 90% of our cells were sensitive to cADPR.
Intracellular glucose inhibits cADPR-evoked Ca 2+ spiking
When 10 mM glucose (Sigma) was included in the pipette solution, cADPR (10 µM) failed to induce responses in all of the 14 cells tested, whereas in the control cells (without glucose) from the same preparations, investigated in parallel, five out of seven cells displayed cADPR responses ( Figure 1 ).
We also tried two very pure preparations of glucose (Sigmaultra and Aristar). In four cells with 10 mM glucose (Sigmaultra), cADPR failed to evoke any response, whereas in three out of the four control cells, responses to cADPR were found (Figure 1 ). Of the seven cells investigated with 10 mM glucose (Aristar) and cADPR in the pipette solution, five cells failed to spike, whereas two did. In the seven control cells, six responded whereas one did not. In the total of 25 experiments with 10 mM glucose and 10 µM cADPR in the pipette solution, only two cells presented repetitive spikes, most likely of a spontaneous nature.
We also used lower glucose concentrations. At 2.5 mM there were no responses to cADPR in the eight cells tested, whereas all four control cells generated spikes. At a glucose concentration of 1 mM, seven out of nine cells failed to respond, whereas all six control cells were able to fire spikes. At 300 µM all six cells investigated failed to evoke spikes whereas all five control cells responded normally to cADPR (Figure 1 ). When 100 µM glucose was present in the pipette solution, three out of five cells failed to respond whereas two did. In the corresponding control series, five cells fired spikes whereas one did not. At a glucose concentration of 30 µM, four out of six cells responded ( Figure 1 ) and two cells failed to generate spikes. In the corresponding control series, all six cells responded. The effect of intracellular glucose was therefore difficult to detect below 100 µM (Figure 1 ).
There is little information about intracellular glucose concentrations in living cells. In single cardiac myocytes, the intracellular glucose concentration reached 60% of the extracellular glucose concentration in the presence of insulin [14] . Cells may therefore have millimolar levels of glucose intracellularly. In the absence of insulin, the intracellular glucose concentration is much lower and is hardly influenced by the extracellular glucose concentration [14] . Considering that the K m for hexokinase is about 30 µM [14] , the intracellular glucose concentration could vary markedly, depending on the insulin concentration, from a few micromolar to a few millimolar. Fluctuations of intracellular glucose in this range could have an important modulatory action on agonist-evoked Ca 2+ signal generation.
To test whether glucose metabolism was essential for the inhibitory effect on cADPR-evoked Ca 2+ spiking, we performed experiments with the stable analogue 2-deoxyglucose. In nine whole-cell recording experiments with 10 mM 2-deoxy-glucose in the pipette solution, cADPR consistently failed to evoke spiking whereas the four control cells all responded with repetitive spikes (Figure 2 ).
The inhibitory effects so far described were due to Dglucose. When 10 mM L-glucose was present in the pipette solution, five out of eight cells displayed normal responses to cADPR (Figure 2 ). In the corresponding control series, all eight cells tested responded to cADPR. Clearly Lglucose does not block cADPR-induced Ca 2+ spiking.
Glucose was always present in the external solution. At room temperature and patch-clamp whole-cell recording (dialysis of intracellular space with pipette solution), glucose entry across the plasma membrane seems insufficient to have any effect on the cytoplasmic glucose level, which is clamped by the glucose concentration in the pipette solution. This was confirmed in three experiments in which we increased the external glucose concentration from 5 to 45 mM without glucose inside the pipette. In each of these three experiments, cADPR evoked spiking, which was not inhibited by the external glucose concentration. Intracellular 2-deoxy-glucose inhibits cADPR-evoked Ca 2+ spiking, whereas L-glucose has no effect. In all cases cADPR (10 µM) was present in the internal pipette solution. Control traces are on the left side. When 2-deoxy-glucose (10 mM) was in the internal pipette solution, cADPR failed to evoke spikes whereas 10 mM L-glucose in the pipette solution had no inhibitory effect. presence of glucose, seen in Figure 3 , are typical. In a second series with 10 mM glucose intracellularly, the initial response to 10 µM 2,4,5-IP 3 was a very broad transient followed by high-frequency spiking (five out of six cells; Figure 3 ). Such initial broad responses have never been observed in the absence of intracellular glucose. We also tested the effect of 2-deoxy-glucose. Nine cells were internally perfused with 10 mM 2-deoxy-glucose and 10 µM 2,4,5-IP 3 . In seven cases, there were clear responses ( Figure 3 ) whereas two cells failed to respond. Of the 10 control cells, seven responded normally ( Figure 3 ) whereas three remained silent. There was no difference between the spike pattern in the presence or absence of 2-deoxy-glucose.
Effects of intracellular glucose and the cADPR antagonist 8-NH 2 -cADPR on CCK-evoked Ca 2+ spiking
In some of our previous patch-clamp whole-cell current recording studies of CCK-evoked Ca 2+ spikes, glucose (10 mM) was included in the internal pipette solution and this did not prevent spiking responses [15, 16] . In other studies, glucose was not present in the pipette solution, but in these cases CCK did also evoke spiking [13, 17] .
The involvement of cADPR receptors in Ca 2+ signal generation can be tested using a cADPR antagonist. The cADPR antagonist 8-NH 2 -cADPR [7] inhibits Ca 2+ signal generation in, for example, sea urchin eggs [18] and heart muscle [19] . In the absence of intracellular glucose, 8-NH 2 -cADPR abolishes Ca 2+ spiking in pancreatic acinar cells evoked by a physiological CCK concentration (5 pM) [8] indicating that cADPR receptors play a role and that at this physiological hormone concentration with low internal glucose there is insufficient IP 3 receptor activation to generate Ca 2+ spikes. We have now compared the effect of this cADPR antagonist on the CCK-evoked response in the presence and absence of 10 mM glucose in the internal solution. In the absence of intracellular glucose the Ca 2+ spiking evoked by 5 pM CCK was, as previously shown [8] , abolished by inclusion of 18 µM 8-NH 2 -cADPR in the pipette solution (Figure 4) , but in the presence of glucose the antagonist failed to block the CCK response (Figure 4 ). In the four control experiments, CCK (5 pM) evoked the usual response. In five out of seven experiments with the antagonist, the cells responded to CCK (5 pM) with long transients and few short-lasting spikes (Figure 4 ).
The cADPR antagonist does not block IP 3 -evoked responses [8] . CCK responses are blocked by heparin, used as a IP 3 receptor antagonist, in the presence of intracellular glucose [16] . In the absence of intracellular glucose, the CCK response seems dominated by Ca 2+ release from cADPR receptors, whereas at a high intracellular glucose concentration it may be mainly due to activation of IP 3 receptors. Isolated liver nuclei can release Ca 2+ from the nuclear envelope store in response to both IP 3 and cADPR [20] , and isolated zymogen granules from pancreatic acinar cells also release Ca 2+ in response to either of these messengers [21] . Both these sets of experiments [20, 21] were carried out in glucose-free solutions.
CCK stimulates glucose entry in pancreatic acinar cells [22] and potentiates CCK-induced amylase secretion [23] , partly due to insulin release [24] . The IP 3 -evoked Ca 2+
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Figure 4
The cADPR antagonist 8-NH 2 -cADPR inhibits CCK-evoked Ca 2+ spiking in the absence of intracellular glucose but fails to inhibit when glucose is present intracellularly. The control traces (left) show the normal effects of CCK (5 pM) in the absence or presence of glucose intracellularly. In the absence of intracellular glucose (top) 8-NH 2 -cADPR (18 µM), when present in the internal pipette solution, blocks the CCKinduced response. In the presence of glucose (10 mM) intracellularly, the cADPR antagonist fails to block the CCK response (bottom). spiking is enhanced by glucose (Figure 3) . The inhibitory effect of the cADPR antagonist on the CCK response, in the absence of glucose, can be overcome by increasing the CCK concentration [8] . CCK-evoked glucose entry may stimulate the IP 3 receptors.
The opposite effects of intracellular glucose on cADPRevoked and IP 3 -evoked Ca 2+ spiking (Figures 1 and 3 
Materials and methods
Isolated single and double mouse pancreatic acinar cells were prepared by pure collagenase (100 U/ml; Worthington Biochemical Corp) digestion in the presence of trypsin inhibitor (3.5 mg/ml Sigma) as described previously [6, 12] . The cells were investigated using the whole-cell patch-clamp configuration at room temperature. From a holding potential of -30 mV, steps were made to 0 mV, the reversal potential of the two Ca 2+ -dependent currents [12] . These Ca 2+ -dependent channel currents were used to monitor cytosolic Ca 2+ concentration changes [11, 13, 15] . The extracellular Na + -rich solution contained 140 mM NaCl, 4.7 mM KCl, 1.13 mM MgCl 2 , 5 or 10 mM glucose, 1 mM CaCl 2 and 10 mM HEPES-NaOH pH 7.2. CCK octapeptide was added to the external solution as indicated. 
